Determine the risk adjusted present value of a biotechnology company after considering the risk factors below (2 marks ) The biotechnology company has developed a new anti cancer drug for Cancer X Risk Factor Probabilty Present Value Company achieving strong patent protection for the new drug in desired jurisdictions around the world 90 $25,000,000 Company has a more effective drug treatment than a competitor that is also developing a drug for the same Cancer X 85 Company achieves licensing deal with a pharmaceutical company in the first 12 months of devlopment of this potential new drug for Cancer X 5 FDA in the United States grants final approval for use of this drug in Cancer X patients 10 Phase II trials show effective treatment of the disease after use of this new drug 70 Marketing shows public support and acceptance of this new drug 100 SECTION 3 THE QUESTIONS BELOW RELATE TO ANTISENSE THERAPEUTICS LIMITED, AN AUSTRALIAN BASED BIOTECHNOLOGY COMPANY What does the company Antisense Therapeutics do (3 marks) What is the current market capitalisation of Antisense Therapeutics (1 mark) Who is the CEO of the company (1 mark) What is the current share price of Antisense Therapeutics (1 mark) What was the share price of the Company at 30 June 2015 (1 mark) Does the Company hold intellectual property rights If so, how many (registered or in the process of being registered) (2 marks) Is the company also licensing intellectual property from another company If so, name the company (2 marks) What is the total equity in the company for the year ended 30 June 2019 (1 mark) What amount of cash was received from Government grants for the year ended 30 June 2019 (1 mark) The Company has highlighted the importance of the compound ATL1102 What is ATL1102 and what disease is it being used to treat Does the company own the IP rights to this compound (2 marks) What is the Companys plan to move forward with the testing of this drug (5 marks) Did the Companys make a net financial profit or loss for the year ending 30 June 2019 What was the figure (2 marks)

The Answer is in the image, click to view ...

Answered step by step

Verified Expert Solution

Link Copied!

Question

1 Approved Answer

Posted on Sep 18, 2024

Determine the risk-adjusted present value of a biotechnology company after considering the risk factors below. (2 marks)

The biotechnology company has developed a new anti-cancer drug for Cancer X.

Risk Factor	Probabilty	Present Value
Company achieving strong patent protection for the new drug in desired jurisdictions around the world.	90%	$25,000,000
Company has a more effective drug treatment than a competitor that is also developing a drug for the same Cancer X.	85%
Company achieves licensing deal with a pharmaceutical company in the first 12 months of devlopment of this potential new drug for Cancer X.	5%
FDA in the United States grants final approval for use of this drug in Cancer X patients.	10%
Phase II trials show effective treatment of the disease after use of this new drug.	70%
Marketing shows public support and acceptance of this new drug.	100%

SECTION 3:

THE QUESTIONS BELOW RELATE TO ANTISENSE THERAPEUTICS LIMITED, AN AUSTRALIAN BASED BIOTECHNOLOGY COMPANY:

What does the company Antisense Therapeutics do? (3 marks)
What is the current market capitalisation of Antisense Therapeutics? (1 mark)
Who is the CEO of the company? (1 mark)
What is the current share price of Antisense Therapeutics? (1 mark)
What was the share price of the Company at 30 June 2015? (1 mark)
Does the Company hold intellectual property rights? If so, how many (registered or in the process of being registered)? (2 marks)
Is the company also licensing intellectual property from another company? If so, name the company. (2 marks)
What is the total equity in the company for the year ended 30 June 2019? (1 mark)
What amount of cash was received from Government grants for the year ended 30 June 2019? (1 mark).
The Company has highlighted the importance of the compound ATL1102. What is ATL1102 and what disease is it being used to treat? Does the company own the IP rights to this compound? (2 marks)
What is the Companys plan to move forward with the testing of this drug? (5 marks)
Did the Companys make a net financial profit or loss for the year ending 30 June 2019? What was the figure? (2 marks)